声动力疗法
纳米医学
线粒体
肿瘤微环境
免疫原性细胞死亡
化学
免疫疗法
癌症研究
细胞凋亡
程序性细胞死亡
医学
免疫系统
生物化学
免疫学
材料科学
纳米技术
肿瘤细胞
活性氧
纳米颗粒
作者
Xipeng Li,Qin Zeng,Ruijing Zhang,Jiajun Li,Guohai Liang,Tao� Zhang
标识
DOI:10.1016/j.cej.2022.138210
摘要
Conventional sonodynamic therapy (SDT) is still limited in conquering localized tumors owing to its low reactive oxygen species (ROS)-based therapeutic effect and undesirably inhibiting effect of immunosuppressive tumor microenvironment (ITM). In this study, we reasonably designed a new sonosensitizer, gadolinium (III) porphyrinate (GdPorP), which could efficiently produce ROS upon ultrasound irradiation and specifically accumulate in mitochondria. The GdPorP-based mitochondria-specific sonodamage could induce high-efficiency cell apoptosis and cascade to producing large-scale immunogenic cell death. After GdPorP systematically delivered together with the indoleamine 2,3-dioxygenase (IDO) inhibitor by a pH-sensitive nanomedicine, the localized liver tumor was specifically mapped by the "switching-on" MRI. And the nanomedicine could not only efficiently suppress the progression of primary liver tumors but also simultaneously boost the systematic antitumor immune effect via the inhibition of ITM. The GdPorP-approved sonodynamic-immunotherapy (SDIT) has thereby been established as a new paradigm for upgrading the efficacy of cancer SDT.
科研通智能强力驱动
Strongly Powered by AbleSci AI